SEC Form 4 · accession 0001179110-17-015860
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nesli Basgoz
Director
Period of report
Mar 29, 2017
Accepted (ET)
Dec 26, 2017 · 7:28 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F3 | Mar 29, 2017 | L | 6 | $242.21 | A | 5,481 | D | |
| Ordinary Shares, par value $0.0001F2,F3 | Jun 16, 2017 | L | 7 | $235.96 | A | 6,043 | D | |
| Ordinary Shares, par value $0.0001F3 | Dec 8, 2017 | G | 45 | $0.00 | D | 5,998 | D | |
| Ordinary Shares, par vaule $0.0001F3 | Dec 8, 2017 | G | 15 | $0.00 | D | 5,983 | D | |
| Ordinary Shares, par value $0.0001F3 | Dec 8, 2017 | G | 6 | $0.00 | D | 5,977 | D | |
| Ordinary Shares, par value $0.0001F3 | Dec 8, 2017 | G | 15 | $0.00 | D | 5,962 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 6.3630 shares acquired on March 29, 2017 pursuant to a broker-assisted dividend reinvestment plan.
- F2Includes shares reported on previously-filed Form 4s on May 5, 2017 and May 22, 2017, and includes 6.55 shares acquired on June 16, 2017 pursuant to a broker-assisted dividend reinvestment plan.
- F3Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.